Products

Onclara™ (by Onc.ai)
Onc.ai
Clinical Decision Support & Reference
Onc.ai develops AI-powered technology, including the Onclara™ platform, to improve oncology decision-making in clinical trials and practice by leveraging real-world oncology data for predictive and prognostic models.

See all 1 product →

About Onc.ai

Onc.ai is a privately held digital health company dedicated to enhancing oncology decision-making through AI-powered technology. The company’s mission is to bring clarity to cancer treatment decisions in both clinical trials and clinical practice by leveraging deep learning imaging AI.

The core of their technology is the Onclara™ platform, which utilizes a market-leading oncology real-world dataset to develop best-in-class predictive and prognostic AI models. Onc.

Focus Areas

AI in oncology precision oncology deep learning imaging radiomics clinical decision support pharmaceutical clinical development metastatic lung cancer immunotherapy response prediction

Business Intelligence

TechnologyCloud-based analytics interface, deep learning imaging platform, multimodal modeling approach, leverages Valohai MLOps platform on Oracle Cloud Infrastructure (OCI) for GPU workloads across AWS, Azure, and GCP.

What Physicians Need to Know

Specialization
AI-powered technology for oncology decision-making, focusing on deep learning imaging, radiomics, and predictive/prognostic AI models for cancer treatment.
Key Differentiators
Leverages a market-leading oncology real-world dataset to train best-in-class predictive and prognostic AI models. Products include Onclara™ Evaluate for clinical trial decision-making (FDA-breakthrough designated) and Onclara™ IO for predicting response and outcomes in metastatic lung cancer patients treated with Immunotherapy.
Technology Stack
Deep Learning imaging AI, AI/ML research, computer vision, and radiomics.
Products
Onclara™ Evaluate (for Phase IB/Phase II clinical trials, FDA-breakthrough designated) and Onclara™ IO (predicts response/outcomes for metastatic lung cancer and immunotherapy patients).
Physician Tip

Onc.ai's Onclara™ platform offers AI-powered tools to enhance decision-making in oncology. For clinical trials, Onclara™ Evaluate can improve decision-making in Phase IB/Phase II studies. For clinical practice, Onclara™ IO provides predictive insights for response and outcomes in metastatic lung cancer, especially for patients undergoing immunotherapy, potentially aiding in personalized treatment strategies.

The official website text does not explicitly mention specific integrations with other systems or platforms, beyond leveraging a market-leading oncology real-world dataset for model training.

Products by Onc.ai

1 product in the directory

Onclara™ (by Onc.ai)
Onc.ai
Clinical Decision Support & Reference
Onc.ai develops AI-powered technology, including the Onclara™ platform, to improve oncology decision-making in clinical trials and practice by leveraging real-world oncology data for predictive and prognostic models.

Videos

News, demos, and interviews about Onc.ai.

Loading videos...

Videos load interactively. If none appear, search YouTube for Onc.ai →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Onc.ai is a digital health company focused on improving oncology decision-making through AI-powered technology.
The Onclara™ platform uses a real-world oncology dataset to train predictive and prognostic AI models.
Onclara™ Evaluate improves decision-making for leading pharmaceutical companies in Phase IB/Phase II clinical trials.
Onclara™ IO predicts response and outcomes for metastatic lung cancer patients treated with immunotherapy.
Onc.ai uses deep learning imaging AI to bring clarity to decision-making in oncology clinical trials and clinical practice.

Investors

Who's funded Onc.ai.

Related Companies

Stanford University, through its online learning platform Stanford Online (online.stanford.edu), provides a wide array of educational opportunities, including those focused on Artificial Intelligence (AI) in healthcare. Stanford Online aims to extend the university’s academic excellence and breakthrough research to a global audience, offering programs taught by Stanford faculty and industry experts. These offerings range from […]

Radin Health offers a comprehensive suite of AI-powered, cloud-based solutions designed to enhance operational efficiency across all stages of the radiology workflow. Their platform integrates a Radiology Information System (RIS), Picture Archiving and Communication System (PACS), AI-driven Dictation, and RADIN SELECT for workflow management. These solutions aim to improve efficiency and productivity for administrators, medical […]

Google Workspace provides a comprehensive suite of secure online productivity and collaboration tools designed for various organizational sizes, including businesses, enterprises, and frontline workers. For physicians and healthcare professionals, Google Workspace offers a secure environment for communication, data storage, and document management, which is crucial for maintaining patient confidentiality and operational efficiency. The platform integrates […]

Pacmed is an Amsterdam-based clinical intelligence company that develops and implements AI solutions to improve hospital care, with a particular focus on the Intensive Care Unit (ICU). The company’s core product, Pacmed Critical, is an AI platform designed to optimize ICU capacity, enhance patient outcomes, and provide data-driven insights for medical professionals. This platform integrates […]

AiZtech Labs is a pioneering deep tech company that leverages AI to transform healthcare by providing accessible and rapid screening tools. Their mission is to enhance the quality of life for one billion people by blending world-class AI research with human-centered design. The company’s flagship platform, iSelfie BioSignals, utilizes a smartphone camera to detect digital […]

Spectrum Dynamics Medical is a pioneering medical device company focused on transforming nuclear medicine from analog to digital technology. They specialize in developing high-definition, solid-state based nuclear imaging technology, including digital SPECT (Single Photon Emission Computed Tomography) and SPECT/CT systems. Their products aim to meet the clinical needs and workflow demands of diagnostic imaging departments […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.